Cargando…
CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091306/ http://dx.doi.org/10.1016/S0735-1097(21)02187-2 |
| _version_ | 1783687454727864320 |
|---|---|
| author | Ilonze, Onyedika J. Ballut, Kareem Jones, Mark Rao, Roopa Guglin, Maya |
| author_facet | Ilonze, Onyedika J. Ballut, Kareem Jones, Mark Rao, Roopa Guglin, Maya |
| author_sort | Ilonze, Onyedika J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8091306 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | American College of Cardiology Foundation. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80913062021-05-03 CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 Ilonze, Onyedika J. Ballut, Kareem Jones, Mark Rao, Roopa Guglin, Maya J Am Coll Cardiol Heart Failure and Cardiomyopathies American College of Cardiology Foundation. Published by Elsevier Inc. 2021-05-11 2021-05-03 /pmc/articles/PMC8091306/ http://dx.doi.org/10.1016/S0735-1097(21)02187-2 Text en © 2021 American College of Cardiology Foundation Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Heart Failure and Cardiomyopathies Ilonze, Onyedika J. Ballut, Kareem Jones, Mark Rao, Roopa Guglin, Maya CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title | CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title_full | CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title_fullStr | CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title_full_unstemmed | CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title_short | CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19 |
| title_sort | clinical characteristics, outcomes and immunosuppression strategies of heart transplant recipients infected with covid-19 |
| topic | Heart Failure and Cardiomyopathies |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091306/ http://dx.doi.org/10.1016/S0735-1097(21)02187-2 |
| work_keys_str_mv | AT ilonzeonyedikaj clinicalcharacteristicsoutcomesandimmunosuppressionstrategiesofhearttransplantrecipientsinfectedwithcovid19 AT ballutkareem clinicalcharacteristicsoutcomesandimmunosuppressionstrategiesofhearttransplantrecipientsinfectedwithcovid19 AT jonesmark clinicalcharacteristicsoutcomesandimmunosuppressionstrategiesofhearttransplantrecipientsinfectedwithcovid19 AT raoroopa clinicalcharacteristicsoutcomesandimmunosuppressionstrategiesofhearttransplantrecipientsinfectedwithcovid19 AT guglinmaya clinicalcharacteristicsoutcomesandimmunosuppressionstrategiesofhearttransplantrecipientsinfectedwithcovid19 |